All-Oral Treatment Combo for AML Earns FDA Nod

Published Date: 15 May 2026

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Brain MRI Surveillance Alone May Be Enough in SCLC

2.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

3.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

4.

All-Oral Treatment Combo for AML Earns FDA Nod

5.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot